Belgium· BE-AMP-SAM663102-00

Eliquis 0.15 mg

A apixaban product containing apixaban, registered in Belgium by Bristol Myers Squibb/Pfizer. The same ATC class is registered in 17 of our 19 countries.

ATC B01AF02

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about apixabanAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Apixaban is registered in 17 of 19 countries.

Countries holding a registration under ATC B01AF02 (apixaban), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search apixaban products by name

Apixaban · ATC B01AF02

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of apixaban costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $3.38 in France to $7.97 in Italy — a ×2.4 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Apixaban · price per daily dose (10 mg)

USD · FX 28 Sept 2026

IT Italy$7.97
CH Switzerland$4.70
FR France$3.38

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Apixaban
Manufacturer: Bristol Myers Squibb/Pfizer
Country: Belgium (BE)
ATC code: B01AF02
ATC class: Apixaban
Defined daily dose: 10 mg, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

398 interactions on record for apixaban.

Graded by severity as the source publishes them — 133 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check apixaban against other medicines How interaction checks work

Apixaban · interactions on record

398 records

133 severe
224 moderate
2 minor

Most severe, free to view

LonafarnibA16AX20severe
DicoumarolB01AA01severe
WarfarinB01AA03severe
HeparinB01AB01severe

39 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Apixaban in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All apixaban products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Abatixent, Apixaban +pharma
Bulgaria · Abatixent, Apixaban
Cyprus · Abidalo, Apixaban
Czechia · Aboxoma, Apixaban
Germany · Abidalo, Akkirateron
Denmark · Apinovia, Apinovia 5 Mg Film-Coated Tablets
Estonia · Abatixent, Aboxoma
Spain · Apicassa, Apiclot
Finland · Apiclodem, Apixaban
France · Apixaban, Apixaban Aet
United Kingdom (Northern Ireland) · Apixaban, Apixaban Abdi
Greece · Abixatec, Aboxoma
Croatia · Abatixent, Abidalo
Hungary · Aboxoma, Apixaban
Ireland · Apixaban Abdi, Apixaban Aristo
Iceland · Apixaban Accord, Apixaban Krka
Italy · Apilion, Apixaban Abdi
Liechtenstein · Apixaban Accord, Eliquis
Lithuania · Abatixent, Aboxoma
Luxembourg · Apixaban Eg, Apixaban Ratiopharm
Latvia · Abatixent, Aboxoma
Malta · Abidalo, Antixara
Netherlands · Abatixent, Apilion
Norway · Apixaban Accord, Apixaban Axunio
Poland · Abatixent, Aboxoma
Portugal · Apixaban Grindeks, Apixabano Alter
Romania · Abatixent, Aboxoma
Sweden · Apixaban, Apixaban Axunio
Slovenia · Abatixent, Aboxoma
Slovakia · Aboxoma, Apixaban

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/aae83252-e432-42da-83b4-f62914d655ff
GET /v1/drugs/aae83252-e432-42da-83b4-f62914d655ff?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Granules in single-dose container",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Eliquis 0.15 mg",
  "name_fr": "Eliquis 0.15 mg",
  "name_nl": "Eliquis 0.15 mg",
  "amp_code": "SAM663102-00",
  "strengths": [
    "0.1500",
    "0.1500",
    "124.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Apixaban",
    "Lactose",
    "Propylene Glycol",
    "Sodium Laurilsulfate",
    "Sucrose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Apixaban",
  "authorisation_numbers": [
    "EU/1/11/691/016"
  ]
}

API reference MCP server Plans

See everything about apixaban.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console